Stay Informed: Bookmark MOAAs advocacy news page for the latest on this issue and others, and be sure youve registered at our Legislative Action Center so you can receive updates from our advocacy team

Wegovy (Novo Nordisk) Patient Support Program Eligibility: Must have private insurance that covers Wegovy, not receiving government drug benefits Savings: Up to $150 per monthly prescription for 12 months Maximum annual benefit: $1,800 How it works: Reduces out-of-pocket costs after insurance pays their portion Saxenda (Novo Nordisk) Patient Support Program Eligibility: Private insurance covering Saxenda, not on provincial drug plans Savings: Up to $120 per monthly prescription Maximum annual benefit: $1,440 How it works: Applied at pharmacy, reduces copay amount Expected Retatrutide Program (Not Yet Announced) Projected eligibility: Private insurance with Retatrutide coverage, not receiving provincial benefits Projected savings: $200-300 per monthly prescription based on medication cost Projected maximum benefit: $2,400-3,600 annually Expected launch: Same time as Health Canada approval The catch with Canadian savings programs: you need private insurance that already covers the medication

For someone who wants medical support for weight loss without taking time off work for in-person visits, that's the appeal: an online intake, a licensed provider's review, and delivery to your door - no waiting room required
This documentation serves multiple purposes

Compounding Pharmacy Economics Compounded Medication Costs: Raw Materials: Pharmaceutical-grade tirzepatide (API) Purchased from legitimate suppliers No development costs (existing drug) Cost: ~$65-100 per maximum dose Compounding Labor: Licensed pharmacists preparing medication Sterile compounding cleanroom USP Chapter 797 compliance Quality control testing Labor cost: ~$30-50 per patient/month Facility & Operations: FDA-registered compounding pharmacy Sterile cleanroom maintenance Equipment and supplies State pharmacy licensing Regulatory compliance Allocated cost: ~$40-60 per patient/month Quality Control: Sterility testing Potency verification Beyond-use date establishment Documentation Cost: ~$20-30 per patient/month Overhead: Pharmacy staff salaries Utilities and rent Insurance and licensing Technology systems Allocated cost: ~$30-50 per patient/month Total Compounding Cost: ~$185-290 per patient/month Telehealth Provider Markup: Medical oversight: ~$50-100/month Technology platform: ~$20-40/month Customer support: ~$20-40/month Profit margin: ~$40-170/month Final Price: $349-699/month What Compounding Eliminates No R&D Costs: Tirzepatide already developed by Eli Lilly Clinical trials completed FDA approval achieved Compounders use existing knowledge No Marketing Costs: Minimal advertising Word-of-mouth and organic growth No sales force No TV commercials No Complex Distribution: Direct from pharmacy to patient No PBM middlemen No rebate system No wholesaler markup Lower Profit Expectations: Smaller companies No public shareholders No Wall Street pressure Sustainable margins vs maximum extraction Result: 67-80% lower price for identical active ingredient

10.1016/j.nut.2005.06.003 10 HanahanD.FolkmanJ